- Home
- PDFS vs LENZ Comparison
PDFS vs LENZ Comparison
Compare PDFS & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDFS
- LENZ
- Stock Information
- Founded
- PDFS 1992
- LENZ 2019
- Country
- PDFS United States
- LENZ United States
- Employees
- PDFS N/A
- LENZ N/A
- Industry
- PDFS EDP Services
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- PDFS Technology
- LENZ Health Care
- Exchange
- PDFS Nasdaq
- LENZ Nasdaq
- Market Cap
- PDFS 768.7M
- LENZ 819.1M
- IPO Year
- PDFS N/A
- LENZ 2021
- Fundamental
- Price
- PDFS $19.56
- LENZ $29.94
- Analyst Decision
- PDFS Strong Buy
- LENZ Strong Buy
- Analyst Count
- PDFS 3
- LENZ 5
- Target Price
- PDFS $33.33
- LENZ $41.80
- AVG Volume (30 Days)
- PDFS 202.8K
- LENZ 274.7K
- Earning Date
- PDFS 08-07-2025
- LENZ 05-07-2025
- Dividend Yield
- PDFS N/A
- LENZ N/A
- EPS Growth
- PDFS N/A
- LENZ N/A
- EPS
- PDFS 0.03
- LENZ N/A
- Revenue
- PDFS $185,933,000.00
- LENZ N/A
- Revenue This Year
- PDFS $23.39
- LENZ N/A
- Revenue Next Year
- PDFS $18.37
- LENZ $544.79
- P/E Ratio
- PDFS $539.89
- LENZ N/A
- Revenue Growth
- PDFS 11.75
- LENZ N/A
- 52 Week Low
- PDFS $15.91
- LENZ $16.28
- 52 Week High
- PDFS $39.70
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- PDFS 51.98
- LENZ 54.67
- Support Level
- PDFS $19.34
- LENZ $27.91
- Resistance Level
- PDFS $20.41
- LENZ $30.76
- Average True Range (ATR)
- PDFS 0.67
- LENZ 2.09
- MACD
- PDFS 0.07
- LENZ -0.14
- Stochastic Oscillator
- PDFS 65.14
- LENZ 38.41
About PDFS PDF Solutions Inc.
PDF Solutions Inc offers products and services designed to empower engineers and data scientists across the semiconductor ecosystem to improve the yield, quality, and profitability of their products. The solutions combine proprietary software, physical intellectual property (or IP) for integrated circuit (or IC) designs, electrical measurement hardware tools, various methodologies, and professional services. The company's products and services are sold to integrated device manufacturers (or IDMs), fabless semiconductor companies, foundries, outsourced semiconductor assembly and test (or OSATs), and system houses.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.